Finance Stock Joins Two Elite Lists With 20% Gain; Shares Trading In Buy Range

2026-04-07 20:00:19

Marex (MRX) stock is flexing its technical and fundamental muscles as it wins a spot on two elite lists at Investor’s Business Daily. Shares of the financial services provider are also in a buy range after a recent breakout.

The IBD 50 and IBD Sector Leader holding has risen in the ranks compared with other stocks in the IBD database, for price performance, making it Tuesday’s focus in the IBD 50 group.

				    ↑
					X

This video file cannot be played.(Error Code: 102630)

								MarketSurge 2.0: Here's What To Expect From The New IBD Charting Platform
							

							

								See All Videos
							

						

					
					
						NOW PLAYING
						MarketSurge 2.0: Here's What To Expect From The New IBD Charting Platform

Marex provides clearing services for the commodity, energy and financial markets with access to more than 60 exchanges worldwide.

Its stock is in a cup-with-handle base. The shares formed the 46-week pattern after hitting their all-time high of 49.34 in May 2025. Now, Marex stock is in a buy zone that stretches up to 46.86 following its breakout at a 44.63 buy point in late March.

This is a first-stage base that can net higher gains than later-stage ones. Meanwhile, the stock’s Relative Strength Rating, which was at 36 just four weeks ago, has risen to 87 on a scale of 1-to-99.

Marex’s fourth-quarter earnings, released March 3, came in at $1.13 per share, a 49% leap from a year earlier. Earnings growth accelerated for a second consecutive quarter, helping the stock score an ideal Earnings Per Share Rating of 99. The Composite Rating is nearly ideal, at 98.

Sales of $572 million showed a pickup in growth from the prior two quarters as well as a 38% increase from its December-ended quarter of 2024. Analysts were expecting $1.02 per share on sales of $523 million.

Financial Services Stock Leads Group

Marex’s execution service for the energy and financial markets helps connect buyers and sellers in equities, credit and currency markets. Also, the company is a market maker across several financial asset classes and sells investment and hedging services.

The stock leads the financial services-specialty group, according to IBD Stock Checkup. Marex also leads the finance sector, one of IBD’s 33 sectors.

IBD Newsletters

Get exclusive IBD analysis and actionable news daily.

		SIGN UP NOW!

IBD Newsletters

Get exclusive IBD analysis and actionable news daily.

										*   							
								How To Invest								
								
							
						
										*   							
								Market Prep								
								
							
						
										*   							
								Tech Report

Please enter a valid email address

Please select a newsletter

GO

Get these newsletters delivered to your inbox & more info about our products & services. Privacy Policy & Terms of Use

Thank You!

You will now receive IBD Newsletters

			ALL DONE!

Something Went Wrong!

Please contact customer service

			CLOSE

Institutions have been betting on the stock in the recent 13 weeks, going by its Accumulation/Distribution Rating of B. A total of 73.5% of outstanding shares are in managed portfolios, with more funds taking a stake in Marex in six out of the past seven quarters.

The Up/Down Volume Ratio of 1.3 also indicates high demand for the stock over the past 50 days.

In the IBD mutual fund index, the Invesco Discovery Fund (OPOCX) holds Marex stock.

Shares of Marex went public on April 25, 2024, on the Nasdaq exchange. Its initial public offering was priced at 19 per share.

Find Stocks To Watch: From Top IPOs To Large And Small Caps

The stock’s relative strength line has climbed, scoring a gain of 20% so far in 2026 as of Monday compared with the benchmark S&P 500’s loss of more than 3%.

In 2024, Marex rose 23%, beating the S&P 500’s 16% advance for that year, according to IBD MarketSurge.

Please follow VRamakrishnan on X/Twitter for more news on the stock market today.

YOU MAY ALSO LIKE:

Is Nvidia A Buy?

IBD Live: Learn And Analyze Growth Stocks With The Pros

MarketSurge: Research, Charts, Data And Coaching All In One Place

The Four Pillars Of The IBD Methodology

Risk Management In The Stock Market: How Much Money To Invest

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.